99

Breakthroughs
Sub Categories on Breakthroughs
Latest Articles
New tool to analyze blood platelets holds major medical potential

New tool to analyze blood platelets holds major medical potential

by Carol Clark,Emory UniversityCredit: Pixabay/CC0 Public DomainA novel technique to test platelet function within a person's blood sample is faster, easier and more precise than methods cur

New tool to analyze blood platelets holds major medical potential

by Carol Clark,Emory UniversityCredit: Pixabay/CC0 Public DomainA novel technique to test platelet function within a person's blood sample is faster, easier and more precise than methods cur
Researchers shed light on the molecular causes of different functions of opioid receptors

Researchers shed light on the molecular causes of different functions of opioid receptors

by Anne Grimm,Leipzig UniversityLigand-dependent activation of the µOR.a, Binding of agonist to the µOR activates two downstream signaling pathways: the G-protein pathway and the β-arresti

Researchers shed light on the molecular causes of different functions of opioid receptors

by Anne Grimm,Leipzig UniversityLigand-dependent activation of the µOR.a, Binding of agonist to the µOR activates two downstream signaling pathways: the G-protein pathway and the β-arresti
Unlocking the human genome: Innovative machine learning tool predicts functional consequences of genetic variants

Unlocking the human genome: Innovative machine learning tool predicts functional consequences of genetic variants

byThe Mount Sinai HospitalLoGoFunc identifies harmful (left) and harmless (right) genetic variations in the Vasopressin V2 receptor protein using a structure predicted by AlphaFold2. This helps

Unlocking the human genome: Innovative machine learning tool predicts functional consequences of genetic variants

byThe Mount Sinai HospitalLoGoFunc identifies harmful (left) and harmless (right) genetic variations in the Vasopressin V2 receptor protein using a structure predicted by AlphaFold2. This helps
Study supports use of cystic fibrosis drug in infants from four weeks of age

Study supports use of cystic fibrosis drug in infants from four weeks of age

by RCSI University of Medicine and Health SciencesCredit: Pixabay/CC0 Public DomainA cystic fibrosis drug targeting the basic defect that causes the condition has been shown to be safe and effective i

Study supports use of cystic fibrosis drug in infants from four weeks of age

by RCSI University of Medicine and Health SciencesCredit: Pixabay/CC0 Public DomainA cystic fibrosis drug targeting the basic defect that causes the condition has been shown to be safe and effective i
Researchers uncover unexpected molecular pattern in fragile X syndrome

Researchers uncover unexpected molecular pattern in fragile X syndrome

byPerelman School of Medicine at the University of PennsylvaniaCredit:Cell(2023). DOI: 10.1016/j.cell.2023.11.019Researchers have found new disrupted genes and an unexpected molecula

Researchers uncover unexpected molecular pattern in fragile X syndrome

byPerelman School of Medicine at the University of PennsylvaniaCredit:Cell(2023). DOI: 10.1016/j.cell.2023.11.019Researchers have found new disrupted genes and an unexpected molecula
Research explores liberalization of medical marijuana and mental health in the US

Research explores liberalization of medical marijuana and mental health in the US

by University of BaselRegulation of (medical) marijuana across US states at the end of 2018. Credit:Health Economics, Policy and Law(2024). DOI: 10.1017/S1744133124000033The approval

Research explores liberalization of medical marijuana and mental health in the US

by University of BaselRegulation of (medical) marijuana across US states at the end of 2018. Credit:Health Economics, Policy and Law(2024). DOI: 10.1017/S1744133124000033The approval
Experimental drug that alters gut microbiome shows promise for long COVID relief

Experimental drug that alters gut microbiome shows promise for long COVID relief

by Mary Van Beusekom, CIDRAPProportion of PACS symptoms alleviation by six months. Credit:The Lancet Infectious Diseases(2023). DOI: 10.1016/S1473-3099(23)00685-0A randomized controlled tr

Experimental drug that alters gut microbiome shows promise for long COVID relief

by Mary Van Beusekom, CIDRAPProportion of PACS symptoms alleviation by six months. Credit:The Lancet Infectious Diseases(2023). DOI: 10.1016/S1473-3099(23)00685-0A randomized controlled tr
Research finds T cell subset significantly expands in spleen and brain after virus infection

Research finds T cell subset significantly expands in spleen and brain after virus infection

byScience China Pressslc43a2+T cells differentiate and mature in spleen and are then transported to brain to trigger the production of cytokines involved in antiviral strategies against RG

Research finds T cell subset significantly expands in spleen and brain after virus infection

byScience China Pressslc43a2+T cells differentiate and mature in spleen and are then transported to brain to trigger the production of cytokines involved in antiviral strategies against RG
Research sheds light on effectiveness of FDA's black box warning for asthma drug

Research sheds light on effectiveness of FDA's black box warning for asthma drug

by University of OklahomaCredit: Pixabay/CC0 Public DomainA University of Oklahoma study about a "black box warning" for the asthma drug Singulair continues to influence a national conv

Research sheds light on effectiveness of FDA's black box warning for asthma drug

by University of OklahomaCredit: Pixabay/CC0 Public DomainA University of Oklahoma study about a "black box warning" for the asthma drug Singulair continues to influence a national conv
Your cells are dying. All the time.

Your cells are dying. All the time.

Some go gently into the night. Others die less prettily in freak accidents or deadly invasions, or after a showy display.

Your cells are dying. All the time.

Some go gently into the night. Others die less prettily in freak accidents or deadly invasions, or after a showy display.
Simnotrelvir shortens time to resolution of symptoms in COVID-19

Simnotrelvir shortens time to resolution of symptoms in COVID-19

by Elana GotkineFor adults with mild-to-moderate COVID-19, early administration of simnotrelvir plus ritonavir shortens the time to sustained resolution of symptoms, according to a study published in

Simnotrelvir shortens time to resolution of symptoms in COVID-19

by Elana GotkineFor adults with mild-to-moderate COVID-19, early administration of simnotrelvir plus ritonavir shortens the time to sustained resolution of symptoms, according to a study published in